SLNO

SLNO R&D Expense Growth

-48.29%Fiscal year

Period ending:

SLNO FY R&D Growth (YoY)%
SLNO FY R&D Growth (YoY)243.14%-79.52%
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

SLNO r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Soleno Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-48.2907%
211.9139%
65.0115%
-28.8445%
-7.4943%
42.5647%
126.623%
133.9069%
-40.8128%
14.2973%
102.3107%
-5.7826%
-3.6471%
0%

Compare r&d expense growth

All SLNO financial metrics · SLNO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.